Cargando…
Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells
Radiotherapy is one of the standard treatments for glioma patients; however, its clinical efficacy is limited by radioresistance. We identified a mechanism of such resistance mediated by linc-RA1 (radioresistance-associated long intergenic noncoding RNA 1). Linc-RA1 was upregulated in radioresistant...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492255/ https://www.ncbi.nlm.nih.gov/pubmed/32934196 http://dx.doi.org/10.1038/s41419-020-02977-x |
_version_ | 1783582352777150464 |
---|---|
author | Zheng, Jieling Wang, Baiyao Zheng, Rong Zhang, Jian Huang, Chunyue Zheng, Ronghui Huang, Zhong Qiu, Wenze Liu, Mengzhong Yang, Kaijun Mao, Zixu Ji, Aimin Yuan, Yawei |
author_facet | Zheng, Jieling Wang, Baiyao Zheng, Rong Zhang, Jian Huang, Chunyue Zheng, Ronghui Huang, Zhong Qiu, Wenze Liu, Mengzhong Yang, Kaijun Mao, Zixu Ji, Aimin Yuan, Yawei |
author_sort | Zheng, Jieling |
collection | PubMed |
description | Radiotherapy is one of the standard treatments for glioma patients; however, its clinical efficacy is limited by radioresistance. We identified a mechanism of such resistance mediated by linc-RA1 (radioresistance-associated long intergenic noncoding RNA 1). Linc-RA1 was upregulated in radioresistant glioma cells and glioma tissue samples, compared with radiosensitive cells and nontumor tissues. Linc-RA1 was associated with inferior overall survival and advanced clinical stage of glioma. Linc-RA1 promoted glioma radioresistance in vitro and in vivo. Mechanistically, linc-RA1 stabilized the level of H2B K120 monoubiquitination (H2Bub1) by combining with H2B and inhibiting the interaction between H2Bub1 and ubiquitin-specific protease 44 (USP44), which inhibited autophagy, thus contributing to glioma radioresistance. These results reveal that linc-RA1-mediated autophagy is a key mechanism of radioresistance and is an actionable target for improving radiotherapy efficacy in patients with glioma. |
format | Online Article Text |
id | pubmed-7492255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74922552020-10-01 Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells Zheng, Jieling Wang, Baiyao Zheng, Rong Zhang, Jian Huang, Chunyue Zheng, Ronghui Huang, Zhong Qiu, Wenze Liu, Mengzhong Yang, Kaijun Mao, Zixu Ji, Aimin Yuan, Yawei Cell Death Dis Article Radiotherapy is one of the standard treatments for glioma patients; however, its clinical efficacy is limited by radioresistance. We identified a mechanism of such resistance mediated by linc-RA1 (radioresistance-associated long intergenic noncoding RNA 1). Linc-RA1 was upregulated in radioresistant glioma cells and glioma tissue samples, compared with radiosensitive cells and nontumor tissues. Linc-RA1 was associated with inferior overall survival and advanced clinical stage of glioma. Linc-RA1 promoted glioma radioresistance in vitro and in vivo. Mechanistically, linc-RA1 stabilized the level of H2B K120 monoubiquitination (H2Bub1) by combining with H2B and inhibiting the interaction between H2Bub1 and ubiquitin-specific protease 44 (USP44), which inhibited autophagy, thus contributing to glioma radioresistance. These results reveal that linc-RA1-mediated autophagy is a key mechanism of radioresistance and is an actionable target for improving radiotherapy efficacy in patients with glioma. Nature Publishing Group UK 2020-09-15 /pmc/articles/PMC7492255/ /pubmed/32934196 http://dx.doi.org/10.1038/s41419-020-02977-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zheng, Jieling Wang, Baiyao Zheng, Rong Zhang, Jian Huang, Chunyue Zheng, Ronghui Huang, Zhong Qiu, Wenze Liu, Mengzhong Yang, Kaijun Mao, Zixu Ji, Aimin Yuan, Yawei Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells |
title | Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells |
title_full | Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells |
title_fullStr | Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells |
title_full_unstemmed | Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells |
title_short | Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells |
title_sort | linc-ra1 inhibits autophagy and promotes radioresistance by preventing h2bub1/usp44 combination in glioma cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492255/ https://www.ncbi.nlm.nih.gov/pubmed/32934196 http://dx.doi.org/10.1038/s41419-020-02977-x |
work_keys_str_mv | AT zhengjieling lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT wangbaiyao lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT zhengrong lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT zhangjian lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT huangchunyue lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT zhengronghui lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT huangzhong lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT qiuwenze lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT liumengzhong lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT yangkaijun lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT maozixu lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT jiaimin lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells AT yuanyawei lincra1inhibitsautophagyandpromotesradioresistancebypreventingh2bub1usp44combinationingliomacells |